from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2763c/dfrA

LFCtreatmentdescriptionclass of inhibitor

-0.664

Amikacinug/mL Amikacintranslation

-0.318

Cap5-10ug/mL Capreomycintranslation

-0.297

Rox10-50 ug/mL Roxithromycintranslation

-0.277

SM2-5 ug/mL Streptomycintranslation

-1.846

Tet5-10 ug/mL Tetracyclinetranslation

0.764

Rif0.2-5ug/mL Rifampicintranscription

0.238

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.161

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.964

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.314

CPZ10-50 ug/mL Chlorpromazinerespiration

0.196

Clofazimine10-13 ug/mL Clofaziminerespiration

0.705

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.286

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.740

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.047

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.298

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.221

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.996

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.112

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.359

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.876

KCN5-20 ug/mL Potassium cyaniderespiration

-0.745

NaN30.2-2 mM Sodium aziderespiration

0.560

Nigericin50 uM Nigericinrespiration

-0.617

TRC10-150 ug/mL Triclosanrespiration

-1.269

TRZ10-25 ug/mL Thioridazinerespiration

0.614

Valinomycin0.5-10 uM Valinomycinrespiration

0.758

ZnSO42 mM ZnSO4respiration

-0.617

menadione6-10 ug/mL Menadionerespiration

-0.250

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.576

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.090

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.575

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.096

NRP_1Non-replicating persistence stage 1dosRassociated

0.477

Amp0.2mg/mL AmpicillincellWall

0.149

Cephalexin20-100 ug/mL CephalexincellWall

0.205

Cerulenin0.32-5 ug/mL CerulenincellWall

1.314

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.563

EMB10-20 ug/mL EthambutolcellWall

-0.437

Eta12-40 ug/mL EthionamidecellWall

0.186

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.315

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.531

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.689

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.748

BZA0.12 mg/mL BenzamidearomaticAmides

0.585

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.066

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.317

H2O24 mM hydrogen peroxideDNAdamaging

0.515

Levo10 ug/mL LevofloxacinDNAdamaging

0.631

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.309

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.148

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.793

UVUV-irradiationDNAdamaging

-0.165

ARP41-4 ug/mL Antitubercular compound ARP4?

0.165

Antimycin12.5-50 ug/mL Antimycin A?

0.526

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.216

PA_110-50 ug/mL Antitubercular compound PA-1?

0.321

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.248

PA8240.2-2 ug/mL PA-824?

-1.099

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.171

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.102

Verapamil50 uM Verapamil?

0.570

mercaptoethanol2 mM 2-Mercaptoethanol?

0.776

methoxatin10-20 ug/mL Methoxatin?